Jonca Bull

830 total citations
10 papers, 493 citations indexed

About

Jonca Bull is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Statistics and Probability. According to data from OpenAlex, Jonca Bull has authored 10 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Public Health, Environmental and Occupational Health, 4 papers in Economics and Econometrics and 4 papers in Statistics and Probability. Recurrent topics in Jonca Bull's work include Ethics in Clinical Research (4 papers), Statistical Methods in Clinical Trials (4 papers) and Pharmaceutical studies and practices (3 papers). Jonca Bull is often cited by papers focused on Ethics in Clinical Research (4 papers), Statistical Methods in Clinical Trials (4 papers) and Pharmaceutical studies and practices (3 papers). Jonca Bull collaborates with scholars based in United States. Jonca Bull's co-authors include Anuradha Ramamoorthy, L Zhang, Grant D. Huang, Elizabeth Mahon, Jamie Roberts, Christine Merenda, Richard Pazdur, Anthony J. Murgo, Michel D. Wissing and Paul G. Kluetz and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Pharmacology & Therapeutics.

In The Last Decade

Jonca Bull

10 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonca Bull United States	7	188	107	61	59	59	10	493
Alexandre Vivot France	14	78 0.4×	127 1.2×	43 0.7×	63 1.1×	100 1.7×	29	745
Lockwood G. Taylor United States	14	218 1.2×	64 0.6×	35 0.6×	96 1.6×	47 0.8×	30	758
Benjamin Gregory Carlisle Canada	10	235 1.3×	178 1.7×	80 1.3×	56 0.9×	72 1.2×	30	488
Karen Crowell United States	11	205 1.1×	94 0.9×	156 2.6×	98 1.7×	75 1.3×	25	1.2k
John Valgus United States	14	92 0.5×	111 1.0×	59 1.0×	88 1.5×	14 0.2×	36	643
Steven K. Cheng United States	9	331 1.8×	259 2.4×	72 1.2×	57 1.0×	100 1.7×	13	586
Jeanne M. Regnante United States	3	262 1.4×	181 1.7×	191 3.1×	69 1.2×	76 1.3×	6	630
Sue Hill United Kingdom	9	130 0.7×	72 0.7×	42 0.7×	21 0.4×	83 1.4×	21	565
Stuart Wright United Kingdom	12	72 0.4×	167 1.6×	99 1.6×	34 0.6×	22 0.4×	41	453
Stella Stergiopoulos United States	12	112 0.6×	123 1.1×	67 1.1×	25 0.4×	18 0.3×	28	383

Countries citing papers authored by Jonca Bull

Since Specialization

Citations

This map shows the geographic impact of Jonca Bull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonca Bull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonca Bull more than expected).

Fields of papers citing papers by Jonca Bull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonca Bull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonca Bull. The network helps show where Jonca Bull may publish in the future.

Co-authorship network of co-authors of Jonca Bull

This figure shows the co-authorship network connecting the top 25 collaborators of Jonca Bull. A scholar is included among the top collaborators of Jonca Bull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonca Bull. Jonca Bull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Nugent, Bridget M., Rajanikanth Madabushi, Victor Crentsil, et al.. (2021). Heterogeneity in treatment effects across diverse populations. Pharmaceutical Statistics. 20(5). 929–938. 6 indexed citations

Huang, Grant D., et al.. (2018). Clinical trials recruitment planning: A proposed framework from the Clinical Trials Transformation Initiative. Contemporary Clinical Trials. 66. 74–79. 174 indexed citations

Ramamoorthy, Anuradha, Todd C. Knepper, Christine Merenda, et al.. (2018). Demographic Composition of Select Oncologic New Molecular Entities Approved by the FDA Between 2008 and 2017. Clinical Pharmacology & Therapeutics. 104(5). 940–948. 17 indexed citations

Avilés‐Santa, Larissa, John Heintzman, Nangel M. Lindberg, et al.. (2017). Personalized medicine and Hispanic health: improving health outcomes and reducing health disparities – a National Heart, Lung, and Blood Institute workshop report. BMC Proceedings. 11(S11). 11–11. 20 indexed citations

Fashoyin‐Aje, Lola A., Laura L. Fernandes, Steven J. Lemery, et al.. (2017). Racial composition in trials supporting the U.S. approval of anti-cancer new molecular entities (NMEs): 2011- 2016.. Journal of Clinical Oncology. 35(15_suppl). 6518–6518. 6 indexed citations

Fashoyin‐Aje, Lola A., Laura L. Fernandes, Steven J. Lemery, et al.. (2017). Asian representation in clinical trials of new drugs for the treatment of cancer.. Journal of Clinical Oncology. 35(15_suppl). 6564–6564. 1 indexed citations

Ramamoorthy, Anuradha, et al.. (2015). Racial/ethnic differences in drug disposition and response: Review of recently approved drugs. Clinical Pharmacology & Therapeutics. 97(3). 263–273. 232 indexed citations

Bull, Jonca, et al.. (2015). Type 2 Diabetes in the Pima Indians of Arizona – A Review. Health Behavior and Policy Review. 2(6). 485–492. 1 indexed citations

Wissing, Michel D., Paul G. Kluetz, Yang‐Min Ning, et al.. (2014). Under‐representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993‐2013. Cancer. 120(19). 3025–3032. 31 indexed citations

10.

Chang, Mark, et al.. (2007). Innovative Approaches in Drug Development. Journal of Biopharmaceutical Statistics. 17(5). 775–789. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact